HTA72 Survival Extrapolation for Immuno-Oncology Drugs: Pessimism or Optimism? a Targeted Literature Review and a Validation-Based Case Study

Abstract

Authors

TH Phung

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×